ArticleBMC public health2026
Study protocol for evaluating integrated urban development plans: impacts on health, social equity, and environmental sustainability in Germany.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe urban environment plays a significant role in shaping residents' health, wellbeing, and opportunities for social participation. Urban development interventions have been shown to positively influence physical activity, mental health, quality of life, and self-reported health status. However, most previous studies have focused on single measures or specific environmental aspects. Integrated Urban Development Plans (IUDPs), by contrast, combine interventions from multiple domains, such as housing, infrastructure, green spaces, and social participation, to promote health equity and sustainable urban transformation. The SalusTransform project aims to evaluate IUDPs in three German cities regarding their implementation processes as well as their impacts on health, social equity, and ecological sustainability.
methodsWe will compare three IUDP intervention areas with three control areas in the respective cities using a mixed-methods design. Quantitative and qualitative data will be collected to assess both process and outcome quality of the IUDPs. Primary data collections include resident surveys and focus groups, qualitative interviews with stakeholders, as well as environmental and infrastructural assessments, including air-quality measurements, site visits, and observations related to active mobility and urban green spaces. Secondary data on population structure, aggregated health indicators, and local implementation processes will be provided by the municipalities. Analyses will follow a difference-in-differences approach to identify changes attributable to IUDP implementation while accounting for similar developments in the control areas. DISCUSSION: By building a comprehensive database that links health-related, social, and environmental indicators, SalusTransform will provide valuable evidence on the real-world effects of IUDPs. Findings will inform municipalities, policymakers, and practitioners about the effectiveness and transferability of IUDPs and contribute to the institutionalisation of their systematic evaluation. Close collaboration with local authorities will ensure continuous monitoring of changes and strengthen the practical relevance of the research. Targeted communication strategies will be implemented to engage population groups that are often underrepresented in research and urban planning processes.
trial registrationThis study was prospectively registered with the German Clinical Trials Register (DRKS00036042) on May 28th, 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.